Navigation Links
CureLauncher is Described on LIVESTRONG Blog as Modern Platform That Gets People Involved in Advancing New Cancer Treatments

Bloomfield Hills, MI (PRWEB) December 12, 2012

The LIVESTRONG BLOG says the newly launched website takes direct action by providing information on emerging treatments, access to the researchers involved, and actual enrollment to over 500 breast cancer medical research trials. It also gives anyone a direct chance to get involved in funding this research through use of the “crowdfunding” model that has taken the startup world by storm.

Naveen writes “as some involved in the fight against cancer know all too well, one of the most complicated crossroads in the journey is the clinical trials process”. At the recent MAGI Clinical Research Conference in San Diego, it was reported that of the 50,000 clinical trials that took place in the U.S. in 2009, 80 percent were delayed by at least a month due to low enrollment”.

Stephen Goldner, cureLauncher’s Founder and President, was a featured speaker at the Clinical Research conference. “Providing easy access for patients to connect with clinical trials is critical", said Goldner.

Only cureLauncher translates the complex, medical terminology into easy to understand English. It provides the entry questions to determine if a clinical trial is appropriate for anyone’s specific condition. People can submit a Request Form to participate in the trial or call CureLauncher directly to see if they qualify. CureLauncher is free to all users and a concierge person is available to answer any questions.    

CureLauncher is also supporting a new breast cancer treatment from esteemed cancer researcher Dr. Lee Roy Morgan. People can find information about this experimental treatment at cureLauncher and make a donation to advance the treatment. Ninety one percent of the donations go directly to advancing the new drug. Each person who donates $25 or more can email Dr. Morgan directly and receive his confidential reply.

CureLauncher’s Vice President, David Fuehrer, spoke with Naveen. "My connection to the LIVESTRONG Foundation is both professional and very personal. “At 25, I was a natural bodybuilding champion in New York. Four months later, I was diagnosed with testicular cancer”, said David.

“Lance Armstrong’s book helped me cope with my transition from competitive athlete to cancer patient. Five years later, I was diagnosed with testicular cancer a second time. Throughout the past 10 years, the LIVESTRONG Foundation has helped me accept myself and take action. That inspiration is a big part of why I work with cureLauncher to fund new cancer treatments to save lives”.

To learn more about breast cancer clinical trials or make a donation to the new breast cancer treatment, visit
About CureLauncher
CureLauncher is an online platform that advances new cancer treatments. It connects patients to cures and cancer researchers to funding. CureLauncher brings leading cancer researchers and donors together to fund new cures.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. CureLauncher is a New Website That Connects Patients to Trials Across the U.S.
2. Only 16% of Donations go to New Cancer Treatments in Some Charities. With cureLauncher, 91% of Contributions Go Directly to New Cures for Cancer.
3. Nano-FTIR - A new era in modern analytical chemistry
4. Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies
5. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition
6. Biocartis Announces Commercial Launch of a New Biomarker Analysis Platform
7. Automated Online Sample Preparation Comes to Waters UltraPerformance Liquid Chromatography (UPLC) Platform
8. New Crowdfunding Platform, ScitechStarter, Focuses on Science and Technology Innovators
9. VisionGate Reports Advances In Its Cell-CT(TM) Automated 3D Cell Analysis Platform At ASC 2012 Scientific Meeting
10. New England Cord Blood Bank chooses Sepax 2 from Biosafe as their Cord Blood Processing Platform
11. New Report: "Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance" Now Available at
Post Your Comments:
(Date:6/27/2016)... --  Ginkgo Bioworks , a leading organism design ... awarded as one of the World Economic Forum,s ... innovative companies. Ginkgo Bioworks is engineering biology to ... in the nutrition, health and consumer goods sectors. ... including Fortune 500 companies to design microbes for ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal ... Their findings are the subject of a new article on the Surviving Mesothelioma website. ... the blood, lung fluid or tissue of mesothelioma patients that can help point doctors ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
Breaking Biology Technology:
(Date:5/12/2016)... , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 /PRNewswire/ ... product subsidiary of Infosys (NYSE: INFY ), and ... global partnership that will provide end customers with ... banking and payment services.      (Logo: ... area for financial services, but it also plays a fundamental ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
Breaking Biology News(10 mins):